BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28303006)

  • 1. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
    Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
    Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wolbachia bacteria of filarial nematodes: a target for control?
    Taylor MJ; Bandi C; Hoerauf AM; Lazdins J
    Parasitol Today; 2000 May; 16(5):179-80. PubMed ID: 10782070
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.
    Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA
    Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical development of an oral anti-
    Taylor MJ; von Geldern TW; Ford L; Hübner MP; Marsh K; Johnston KL; Sjoberg HT; Specht S; Pionnier N; Tyrer HE; Clare RH; Cook DAN; Murphy E; Steven A; Archer J; Bloemker D; Lenz F; Koschel M; Ehrens A; Metuge HM; Chunda VC; Ndongmo Chounna PW; Njouendou AJ; Fombad FF; Carr R; Morton HE; Aljayyoussi G; Hoerauf A; Wanji S; Kempf DJ; Turner JD; Ward SA
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus.
    Specht S; Mand S; Marfo-Debrekyei Y; Debrah AY; Konadu P; Adjei O; Büttner DW; Hoerauf A
    Parasitol Res; 2008 Nov; 103(6):1303-9. PubMed ID: 18679718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.
    Jacobs RT; Lunde CS; Freund YR; Hernandez V; Li X; Xia Y; Carter DS; Berry PW; Halladay J; Rock F; Stefanakis R; Easom E; Plattner JJ; Ford L; Johnston KL; Cook DAN; Clare R; Cassidy A; Myhill L; Tyrer H; Gamble J; Guimaraes AF; Steven A; Lenz F; Ehrens A; Frohberger SJ; Koschel M; Hoerauf A; Hübner MP; McNamara CW; Bakowski MA; Turner JD; Taylor MJ; Ward SA
    J Med Chem; 2019 Mar; 62(5):2521-2540. PubMed ID: 30730745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
    Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
    Hoerauf A; Mand S; Fischer K; Kruppa T; Marfo-Debrekyei Y; Debrah AY; Pfarr KM; Adjei O; Büttner DW
    Med Microbiol Immunol; 2003 Nov; 192(4):211-6. PubMed ID: 12684759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for the treatment of onchocerciasis and other filarial infections.
    Hoerauf A; Adjei O; Büttner DW
    Curr Opin Investig Drugs; 2002 Apr; 3(4):533-7. PubMed ID: 12090719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Wolbachia, an endosymbiont of Brugia malayi microfilariae, to doxycycline determined by quantitative PCR assay.
    Sungpradit S; Chatsuwan T; Nuchprayoon S
    Southeast Asian J Trop Med Public Health; 2012 Jul; 43(4):841-50. PubMed ID: 23077805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis.
    Ehrens A; Lunde CS; Jacobs RT; Struever D; Koschel M; Frohberger SJ; Lenz F; Fendler M; Turner JD; Ward SA; Taylor MJ; Freund YR; Stefanakis R; Easom E; Li X; Plattner JJ; Hoerauf A; Hübner MP
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007957. PubMed ID: 31986143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
    Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Eagle effect in the Wolbachia-worm symbiosis.
    Bulman CA; Chappell L; Gunderson E; Vogel I; Beerntsen B; Slatko BE; Sullivan W; Sakanari JA
    Parasit Vectors; 2021 Feb; 14(1):118. PubMed ID: 33627171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target.
    Wu B; Novelli J; Foster J; Vaisvila R; Conway L; Ingram J; Ganatra M; Rao AU; Hamza I; Slatko B
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e475. PubMed ID: 19597542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of a filarial phosphate permease that is up-regulated in response to depletion of essential Wolbachia endobacteria.
    Arumugam S; Hoerauf A; Pfarr KM
    Exp Parasitol; 2014 Mar; 138():30-9. PubMed ID: 24480589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-
    Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
    Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
    Sharma R; Al Jayoussi G; Tyrer HE; Gamble J; Hayward L; Guimaraes AF; Davies J; Waterhouse D; Cook DA; Myhill LJ; Clare RH; Cassidy A; Steven A; Johnston KL; Ford L; Turner JD; Ward SA; Taylor MJ
    Sci Rep; 2016 Mar; 6():23458. PubMed ID: 26996237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Wolbachia treatment for lymphatic filariasis.
    Stolk WA; de Vlas SJ; Habbema JD
    Lancet; 2005 Jun 18-24; 365(9477):2067-8. PubMed ID: 15964428
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.
    Hoerauf A; Mand S; Volkmann L; Büttner M; Marfo-Debrekyei Y; Taylor M; Adjei O; Büttner DW
    Microbes Infect; 2003 Apr; 5(4):261-73. PubMed ID: 12706439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.